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Histoplasma capsulatum is a dimorphic fungal zoopathogen of worldwide dis-
tribution that produces a broad spectrum of disease activity. In most cases the
portal of entry is the lung, where inhaled spores and mycelial fragments of the
fungus lodge within the terminal bronchioles and alveoli. Here, transition from
the mycelial phase to the yeast phase ensues, presumably over a period of hours
to days. The mycelial to yeast phase conversion is critical since it is the yeast
form ofH. capsulatum (Hc)' that is responsible for the pathogenesis ofhistoplas-
mosis in nearly all of its clinical manifestations (1).
The earliest pulmonary lesions induced by He yeasts in man and experimental
animals are patches of pneumonitis consisting largely ofparasitized macrophages
(MO) (2-4). He yeasts are thought to be phagocytized by resident pulmonary Mo
within which they multiply with a generation time of -9-11 h (5). Host Mep
appear to be destroyed by the multiplying yeast forms that in turn, are phago-
cytosed by other Mo attracted to the infected site. The multiplication cycle is
repeated within these cells and He yeasts are disseminated from the lung to other
organs by the lympho-hematogenous route. In most cases, the primary lesions in
lung and those at peripheral sites begin to resolve after development of meas-
urable delayed-type hypersensitivity to antigens of He at 10-20 d after inocula-
tion.
During an early phase of infection, MO bind to and phagocytose He yeasts,
thereby providing a highly permissive intracellular environment for multiplica-
tion of the organism. Later, however, after the activation of cell-mediated
immune defenses, He yeasts that are bound and ingested by Mo appear to be
inhibitedor killed. To better understand the crucial process ofinitial recognition
and attachment of He yeasts by phagocytic cells, we have studied the receptor-
ligand interactions between unopsonized He yeasts and human MO derived from
peripheral blood monocytes(PBM)ofnommmune donors. The findings reported
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here show that M¢ bind avidly to unopsonized organisms by a mechanism that
is both temperature- and cation-dependent. The attachment is mediated by the
CR3/LFA-1/p150,95 family of leukocyte adherence-promoting glycoproteins.
Each of these receptors independently can mediate binding of He yeasts. Neither
low-avidity Fc receptors (FcR) nor mannosyl-fucosyl receptors mediate binding
of yeast ligands to the MO surface, and binding activity is not caused by
opsonization of yeasts with complement components secreted locally by MO.
Materials and Methods
Reagents.
￿
mAb 3D9 directed against CRI (6) was provided by Drs. J. O'Shea and E.
Brown, National Institutes of Health, Bethesda, MD; OKMI and OKM10 (7) directed
against the a chain of CR3, 3C 10 (8) directed against a 55 kD protein unique to monocytes
and M0, and 3G8 (9) against the low-avidity FcR of polymorphonuclear (PMN) leukocytes
were prepared as described previously (7, 9). TA-1 was purchased from Hybrid Tech
(San Diego, CA), and TS-1/22 was a generous gift of Timothy Springer, Harvard Medical
School, Boston, MA. Both TA-1 and TS-1/22 recognize the a chain at LFA-1 (10). Leu-
M5 against the a chain of p150,95 (11) was a gift of Dr. Louis Lanier, Becton Dickinson
& Co., Mountain View, CA. 1134 against i3 chain of the CR3/LFA-1/p150,95 glycoproteins
was prepared as described (7), and mAb 60.3, also directed against S chain of these
glycoproteins (12), was provided by Dr. John Hansen, University of Washington, Seattle,
WA . Rabbit polyclonal antibody to human C3 was provided by Dr. Robert Sim, Oxford
University, Oxford, United Kingdom. Sigma Chemical Co. (St. Louis, MO) supplied poly-
L-lysine (PLL), EDTA, polymyxin B, mannan from Saccharomyces cerevisiae X2180, L-
fucose, galactose, N-acetyl galactosamine, N-acetyl-D-glucosamine, D-glucosamine, D-glu-
curonic acid, a-methyl-D-mannoside, D-mannose, scopoletin, sodium m-periodate, horse-
radish peroxidase P8250 type 11, PMA, sodium azide (NaN;3), and aprotinin. ,B-glucan was
a gift of Dr. J. Czop, Harvard Medical School, Boston, MA. Mannosylated BSA was
purchased from B-Y Laboratories, San Mateo, CA. The Greater New York Blood Center
supplied fibronectin (Fn).
Yeasts.
￿
The yeast phase of He strain 217B was maintained as described (13). A clinical
isolate of Torulopsis glabrata was provided by Dr. Timothy Kiehn, Sloan Kettering, New
York. The yeasts were grown in brain/heart infusion broth (Difco Laboratories Inc.,
Detroit, MI) at 37°C with a gyrorotatory speed of 180 rpm. Cultures of He and T.
glabrata were harvested after 36 and 18 h, respectively, and washed twice with PBS by
centrifugation at 327 g for 5 min. A final centrifugation at 30 g for 1 min allowed for
removal of larger cell aggregates. The yeasts were counted in a hemocytometer and
resuspended in PBS to 2 .2 X 10" organisms/ml for addition to MO monolayers.
Cells. Human monocytes were purified from buffy coats on Percoll gradients and
cultured in 12.5% human serum in Teflon beakers as described previously (14). Sheep E
coated with Cab (EC3b), C3bi (EC3bi), or IgG (EIgG) were prepared as described (14).
Attachment of Unopsonized Yeasts and Ligand-coated Erythrocytes.
￿
MO were harvested
from teflon beakers after 4-7 d, washed, and suspended at 0.5-1 .0 X 10''/ml in PBS
containing 3 mM glucose, 0.5 mg/ml human serum albumin (HSA) (Worthington Bio-
chemical Corp., Freehold, NJ), and 0.3 U/ml aprotinin. Terasaki tissue culture plates
(Miles Laboratories Inc., Naperville, IL) were coated with HSA (1 mg/ml) or mAbs (20-
50 Ag/ml) by a 60-min incubation at 20 ° C. The culture surfaces were washed, 5 A1 of MO
suspension were added per well, and cells were allowed to spread at 37°C for 45 min.
Attachment of test particles to monolayers of Mo was determined by adding 106 yeasts or
5 X 105 ligand-coated E per well and incubating for 45 min at 37°C. The attachment of
particles to Mo was scored by phase microscopy as described (12). Results are reported as
the attachment index (AI), i.e., the percent of phagocytes that attach particles multiplied
by the average number of particles per phagocyte . This figure includes both the attached
and ingested yeasts. All assays were performed in triplicate and at least 100 cells were
counted for each data point.BULLOCK AND WRIGHT
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Antigen/Antibody-bearing Culture Surfaces. IgG-bearing surfaces were prepared by
sequentially treating tissue culture plastic with PLL (Miles Laboratories, Inc., Elkhart,
IN), DNP (Eastman Kodak Co., Rochester, NY), and rabbit anti-DNP IgG as described
by Michl et al. (15). IgM-coated surfaces were prepared in similar fashion by substituting
monoclonal murine IgM anti-DNP (provided by Dr. V. Nussenswig, New York University,
NY) for the IgG anti-DNP.
Nitroblue Tetrazolium (NBT) Reduction.
￿
Spectrophotometric measurement of reduced
NBT was performed by modification of the method of Baehner et al . (16) . A 0.1%
solution of NBT (Sigma Chemical Co., St. Louis, MO) in PBS was prepared fresh daily.
The test system consisted of 0 .2 ml NBT solution, plus 0 .2 ml He yeasts at 5 X 106 or 5
X 10'/ml; PMA (0.1 tag/ml) was used as a positive control and PBS as a negative control .
The reaction mixtures were preincubated for 10 min at 37°C in 12 X 75 siliconized glass
tubes. MO (5 X 105) were then added and tubes were incubated for 20 min at 37° C. He
yeasts, without added M(A, were also used. The reaction was terminated by adding 0.25
N HCl in PBS. The tubes were centrifuged, aspirated, and the purple cell button was
extracted twice with 1 ml of pyridine, reagent grade (Fisher Scientific Co., Fairlawn, NJ),
in a boiling water bath for 10 min. Optical density of the combined extracts was
determined in a spectrophotometer at 515 nm against a pyridine blank.
Similar reagents and controls were used to prepare MO for visual scoring of NBT
reduction . The cells were fixed for 12 h in 1 % paraformaldehyde and 105 cells were
applied to glass slides by a cytocentrifuge (Shandon Southern Instruments Inc., Sewickley,
PA) at 400 g for 5 min. Slides were air dried, stained with modified Wright-Giemsa stain
(Diff Quik, American Scientific Products Div., McGraw Park, IL) and mounted with
Permount (Fisher Scientific Co.) for microscopic examination. At least 100 cells were
counted and the percentage of NBT+ cells was determined.
H,O_ Production.
￿
H20L was measured by a semiautomated scopoletin procedure (17).
Briefly, 100 ul of Mo (0.5 X 10''/ml) were added to wells of a 96-well culture plate,
incubated at 37°C for 90 min, and washed in PBS. The PBS was removed and to each
well was added 100 Al of PBS containing 240 nM of scopoletin, 10 nM NaN3, 3 mM
glucose, and 12 U/ml of horse radish peroxidase. As a control, scopoletin solution was
added to wells containing PBS only. Where indicated, the following triggering agents
were incorporated with the scopoletin solution : PMA at a final concentration of 100
ng/ml, He yeasts (5 X 105/ml-5 X 10''/ml), IgG-coated glass beads (18), and He yeasts (5
X 10"/ml) plus PMA (100 ng/ml). After challenge as above, the secretion of H202 by MO
was quantitated in a plate-scanning fluorometer by recording oxidation of fluorescent
scopoletin to a nonfluorescent product during an interval of 120 min. Results are
expressed as nM of H_02 produced per 5 X 10" Mo.
Results
Temperature and Cation Dependence of He Binding.
￿
A study of the effect of
temperature on the interaction between unopsonized He yeasts and culture-
derived human Mo revealed dramatic differences in the AI at 4° and 37 °C (Fig.
1) . The binding of yeasts to Mo at 37°C was very rapid, such that after only 5
min of incubation, the percentage of yeasts bound was 43% of the maximum AI
of 698 achieved at 60 min . Moreover, the binding of Mo to yeasts was avid since
the Al was not diminished by as many as six washes of the culture wells.
Conversely, at 4°C, there was virtually no binding of yeasts by M4) even after a
90 min period of incubation (AI, 33) .
There is an absolute requirement for divalent cations to support optimal
attachment of Mo to certain ligands, for example, C3bi coated erythrocytes,
whereas cations are not required for binding to other substrates such as the Fc
domain of IgG or C3b-coated erythrocytes (14). To ascertain the role played by
divalent cations in Mcp binding of He yeasts, 5-d cultured monocytes were198
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Temperature dependence of He yeast-binding by MO. Monolayers of Mo (7-d
cultures) were established on surfaces coated with HSA. He yeasts were added to cultures and
the Al was determined serially over a 90-min period in cultures incubated at 0° (O) and at
37'('(9),
TABLE I
Divalent Cation Dependence ofH. capsulatum
Bindingto Macrophages
Attachment index
Exp. l
￿
Exp. 2
Monocytes were cultured for 5 d in Teflon beakers and then were plated
for 45 min in PBS containing 3 mM glucose and then washed thoroughly
in phosphate buffer free of divalent cations. He yeast cells from broth
cultures were similarly washed and suspended in buffer containing the
indicated cations for addition to MO and determination of the attachment
index (Al, the number of He yeasts attached per 100 phagocytes).
coincubated with yeasts in the presence or absence of Ca and Mg ions. The
results of two experiments, summarized in Table 1, demonstrate that both Ca
and Mg ions are required for optimal binding of He yeasts by MO.
Fffect ofmAbs to M0 Surface Receptors on Binding ofHc.
￿
To search forreceptor
molecules on the surfaces of Mo capable of binding unopsonized yeasts of Hc, a
series of mAbs directed against surface antigens of Mo were added individually
to separate sets of wells containing adherent Mo immediately before addition of
yeast cells. Antibody 3G8 directed against low-avidity Fc receptors was without
effect on the AI (Table 11). mAbs OKM1, TA-1, and Leu-M5 are directed against
the CR1, LFA-1, and p150,95 glycoprotein molecules, respectively. Each caused
a partial, but consistent reduction of the AI in four separate experiments. On
the other hand, two mAbs (IB4 and 60 .3) directed against the # chain that is a
common member of the glycoprotein adherence-promoting family, greatly re-
duced the binding of He to Mo (Table 11). These experiments suggest that the
0.5inMCa"and0 .5mMMg" 490 347
0.5 Ink! Ca" 206 61
0.5 mM Mg1+ 22 110
None 66 46TABLE 11
The Attachment of H. capsulatum Yeasts to Macrophages is by Anti-
Receptor mAbs
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Monocytes were cultured for 4-7 d in Teflon beakers. The phagocytes
were allowed to spread on surfaces by incubation for 45 inin at 37°C as
described in Materials and Methods. The adherent phagocytes were
washed, placed on ice, and the indicated anti-receptor antibodies were
added in a concentration of 25 t+g/ml . The binding of He yeasts was
then measured using a 45-min assay. Results are representative of four
separate experiments.
* The mAb is directed against the low-avidity Fc receptor of neutrophils
and reacts weakly with Mo (9).
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CR3/LFA-1/p150,95 family of receptors participates in the recognition of He
yeasts by MO.
Inhibition of He Yeast Binding by Surface-bound Anti-Receptor Antibodies.
Phagocytosis-promoting receptors diffuse freely in the plane of the MO plasma
membrane and function independently of one another in mediating particle
binding (15, 19). Thus, after cells spread on a surface coated with anti-receptor
mAbs, the receptors diffuse to the substrate-adherent domain ofthe cell and are
trapped by interaction with antibody. The apical surface of the cell is thereby
depleted of a single antigen (7). We used this property to remove specifically
individual members of the CR3/LFA-I/p150,95 family of receptors from MO.
Surfaces coated with individual mAbs to each of the three respective a chain
determinants ofthe adherence molecules partially reduced the attachment ofHe
to MO (Fig. 2). However, a greater reduction in AI was achieved by coating
surfaces with any two anti-a chain-directed mAbs, and the greatest reduction
ofAI byanti-a chain mAbswasobtained whenall three were used incombination
as described. In fact, the reduction in binding of Mo to yeasts was of similar
magnitude to that produced by coupling mAb 1114 to the culture surface. The
experiment depicted in Fig. 2 contains a slight anomaly in that the combination
of OKM1 and Leu-M5 caused full reduction in binding of Hc. However, in three
other experiments, the action of OKM1 and Leu-M5 was equivalent to that of
the other pairs ofantibodies. In contrast to these results, removal ofFc receptors
from the apical surfaces of Mo had no effect whatever on the binding of
organisms (Fig. 2). These findings suggest that the capacity to bind He yeasts is
a property shared by all three members of the CR3/LFA-I/p150,95 family.
He and T. glabrata Are Bound by Different Surface Receptors.
￿
MO isolated from
several sources express a surface receptor that recognizes glycoproteins contain-
ing oligosaccharides terminating in mannose (20, 21). This mannosyl/fucosyl
receptor is the principal mechanism by which human Mo bind to zymosan in the
mAb Antigen recognized Attachment
index
None - 657
OKMI a chain, C:R3 488
TA-1 a chain, LFA-1 441
Leu-M5 a chain, p150,95 530
1134 ~ chain, CR3/LFA-1/p150,95 family 120
60.3 /3 chain, CR3/LFA-1/p150,95 family 61
3G8* Low-avidity Fc receptor 596200
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FIGURE 2.
￿
Effect on He yeast-binding of down-regulating MO surface target antigens by
mAb-coated surfaces . mAbs against a chains of the CR3/LFA-1/p150,95 family were used
singly or in combination in a concentration of 50 ag/ml ; IB4 and 3G8 were used singly at 50
jug/ml . The data shownare representative of four experiments .
TABLE III
H . capsulatum yeasts and T . glabrata are Bound to Macrophages by
DifferentSurface Receptors
Monolayers of M¢ (7-d cultures) were allowed to spread on surfaces for 45 min as
described . Adherent phagocytes were washed, placed on ice, and to these were added
mannosylated BSA (50 tlg/ml), mannan (I tug/ml), ormAb IB4 (50 tag/nil) . Thebinding
of He yeasts or T . glabrata was then measured usinga 45-min assay .
absence of serum (22) and by which pulmonary M¢ of mice bind and ingest
Candida krusei (23) . Therefore, we measured the binding of unopsonized He
yeasts by Mo in the presence of soluble ligands that compete for attachment to
the mannosyl/fucosyl receptor . Parallel studies were performed with the oppor-
tunistic yeast pathogen, T . glabrata, chosen for its size proximity to He yeasts
and the absence of germ tube formation. Neither the neoglycoprotein, manno-
syl/BSA, nor yeast-derived mannan exerted detectable blocking activity against
attachment of He (Table III) . However, mannosylated BSA considerably reduced
Mo binding to T . glabrata and mannan greatly decreased the AI . Further
evidence that the respective yeast forms of He and T . glabrata are bound by
different receptors was provided by the finding that mAb IB4 exerted no
blocking activity against the binding of T . glabrata as contrasted with its profound
blockade of M¢ attachment to He yeasts .
Freshly isolated human monocytes do not express mannosyl/fucosyl receptor
Reagent
Concentra-
tion H .
Exp. I
Attachment
capsulatum
Exp. 2
index
T .
Exp.
of:
glabrata
I Exp. 2
taglml
None - 470 522 692 420
Mannosylated BSA 50 451 510 268 ND
Malutan 1,000 473 497 133 40
mAb 1B4 50 - 27 584 403TABLE IV
Bindingof H. capsulatum yeasts and T. glabrata to
Monocytes and Macrophages
Cells used
BULLOCK AND WRIGHT
Attachment index of:
H. capsulatum
￿
T. glabrata
Monocytes
￿
380
￿
31
Macrophages
￿
416 467
Monocytes freshly isolated from peripheral blood as described in Materials
and Methods and 7-d cultured Map were allowed to spread for 45 min.
Tlie attachment of fic yeasts or T. glabrata was then measured using a 45-
min assay.
TABLE V
Fc Receptor Function Is not Required for Attachment ofH. capsulatum Yeasts or T. glabrata
20 1
Mo cultured for 7 d were plated on DNP-anti-DNP IgG or DNP-anti-DNP IgM-coated surface and
on control DNP-coated surfaces. The cells were then washed and the AI measured with He yeasts
and T. glabrata. We used EIgG as a positive control of particle binding, and EC36 and EC36i as
negative binding controls. Results are representative of three separate experiments.
activity, but this receptor is expressed upon in vitro maturation of monocytes
into macrophages (24, 25). Conversely, CR3 is expressed on human blood
monocytes and increases further in activity during the maturation to MO (14).
We thus measured the binding of He and T. glabrata by freshly isolated mono-
cytes and by MO after 7 d in culture (Table IV). The binding of He yeasts to
monocytes was extensive, whereas the AI of Torulopsis yeasts was very low.
However, at day 7, binding of T. glabrata to MO equalled or exceeded the
binding to He yeasts. Taken together, these data strongly suggest that T. glabrata
is recognized by the mannosyl/fucosyl receptor but is not recognized by CR3,
LFA-1, or p150,95. Hc, on the other hand, is bound by the CR3/LFA-1/p150
family of adherence-promoting glycoproteins and is not bound by the manno-
syl/fucosyl receptor.
Recognition ofHe Does Not Require FcR, (3-Glucan Receptors, or Secreted Comple-
ment Proteins. To assess the role of FcR in the binding of Hc, MO were allowed
to spread on surfaces coated with IgG in immune complexes. The attachment of
EIgG by such MO was reduced by 75%, indicating that FcR had been depleted
from the MO (Table V). In contrast, IgM anti-DNP complexes exerted no down
regulation of the bindingof EIgG. Removal of FcR by fixed IgG-DNPcomplexes
did not alter the binding of He yeasts to MO. Thus, FcR are not required for the
binding of He by MO . These data confirm results obtained with mAb 3G8 to the
low-avidity Fc receptor (Table 11, Fig. 2). Data in Table V also demonstrate that
the FcR does not participate in attachment of T. glabrata.
Czop and Austen (26) have observed that several particles that activate the
Surface
H. capsulatum T. glabrata
Attachment index of:
EIgG EC36 EC36i
DN 13 479 497 617 592 636
IgG anti-DNP 475 495 152 582 564
IgM anti-DNf 476 508 629 574 564202
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TABLE VI
Effect ofAntibody to C3 on Bindingby Macrophages ofYeasts,
EC3b, and EIgG
Monocytes Here cultured for 5 d in Teflon beakers and monolayer cultures
were then established. The binding of He yeasts or the indicated ligand-
coated erythrocyte was then measured in the presence of Fab anti-C3
antibody in the concentrations indicated.
alternative pathway of complement are recognized by monocytes, and that this
form ofrecognition can be blocked by low concentrations of,Q-glucan. However,
the AI of Mo to He yeasts was 501 in the presence of 100 ttg/ml of,Q-glucan as
compared with an AI of491 in the control. The concentration of,B-glucan used
is 100-fold greater than that required to inhibit the binding of alternative
pathway activators. Therefore, the #-glucan receptor does not participate in the
binding ofHe yeasts to M¢.
Mo can synthesize all of the classical complement components as well as the
alternative pathway constituents (27), and it has been reported (28) that comple-
ment components secreted by Mo in vitro can opsonize zymosan particles that
activate the alternative pathway. Since He yeasts also activate this pathway (29),
we explored the possibility that these organisms may be opsonized by secreted
MO products. Assays of binding were conducted in the presence of varying
concentrations ofFab fragments of rabbit anti-C3 antibody. Binding of EC3b to
Mo was virtually abrogated by 100 ,ug/ml ofanti-C3, whereas the AI ofHe yeasts
or ofEIgG did not differ from control values (Table VI). It is unlikely therefore,
that Mo attachment can be explained by local opsonization of yeasts by C3 and
subsequent binding to CR3 receptors via C3bi.
Effects ofSoluble Sugars on Attachment ofHe to M¢.
￿
The cell wall of He yeasts
is composed of polymeric carbohydrates, primarily N-acetyl glucosamine and
glucose in the form ofchitin (30). To ask whether a sugar or amino sugar in the
cell wall serves as the recognition site for receptors on M0, we attempted to
block the binding of He yeasts with high concentrations of monosaccharides.
Fucose, a-methylmannoside, glucosamine, N-acetyl glucosamine, or glucuronic
acid (all at 200 mM) produced mild depression of the AI, ranging from 3.4%
With L-fucose to 24.3% with N-acetyl D-glucosamine (Table VII). However, sugar
concentrations of 100 mM and 33 mM, respectively, induced minimal reductions
of binding. Thus, the small reductions in AI produced by all sugars at 200 mM
are likely to have resulted from changes in the osmolarity or ionic strength of
the medium. D-mannose on the other hand, at concentrations of 100 and 200
MM, produced consistent elevations of the AI in four separate experiments of
which two are shown. These experiments suggest that the receptors on MQk that
Concentration of
anti-C3 H. capsulatum
Attachment index of:
EC3b EIgG
Ag/ml
None 492 519 480
25 494 96 441
50 508 21 471
100 454 7 440BULLOCK AND WRIGHT
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TABLE VII
Effect ofSoluble Sugars on Binding ofH. capsulatum
Yeasts to Macrophages
Attachment index
Monocytes were cultured for 7 d in Teflon beakers and monolayer cultures were
then established. The binding of He yeasts was then measured in the presence
of sugars at the concentrations indicated. The pH of all sugars was adjusted to
pH 7.4.
recognize He do not act as lectins for galactose, N-acetyl-galactosamine, fucose,
mannose, a-methyl mannoside, N-acetyl glucosamine, or glucuronic acid. Addi-
tional sugar specificities are currently under study.
NBTReduction and H2O2 Production by MO in Response to He Yeasts.
￿
We asked
whether MOattachment and ingestion ofHe yeasts stimulated a respiratory burst
with formation of toxic oxygen metabolites. The reduction of NBT to blue-
purple formazan by 4-d cultured MO was assessed as a measure ofMO superoxide
activity (16). The results of qualitative and quantitative measurements of NBT
Sugar Concentration
MM
Exp. l Exp. 2 Exp. 3
None - 416 526 465
N-acetyl D-glucosamine 200 315 -
100 469
33 476
D-glucosamine 200 371 -
100 444
33 482
D-glucuronic acid 200 322 -
100 419
33 499
a-methyl D-mannoside 200 403 -
100 408
33 447
t:fucose 200 402 -
100 420
33 488
D-mannose 200 567 -
100 558
33 468
Galactose 200 -
100 412
33 503
N-acetyl-galactosamine 200 -
100 436
33 477204
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TABLE VIII
NBT Reduction by M¢ in Response to H. capsulatum Yeasts
Qualitative and quantitative analyses of NBT reduction by 4-d cultured
MO from sir normal subjects were performed as described in Materials
and Methods. He yeasts were added to Moat ratios of 1 :1 and 10 :1 . PMA
was used at a final concentration of 100 ng/ml . In the absence of Mo, He
yeasts alone did not raise the OD above the background levels produced
by Mo controls. When the quantitative assay was performed with yeasts
alone at 5 X 10°/ml, the concentration corresponding to that added to
yield one yeast per Mo, the OD was 0.015 ± 0.005, and at 5 X 10'/ml,
the OD was 0.036 ± 0.006. This result was confirmed by visual inspection,
which showed negligible NBT associated with free yeasts.
reduction by Mo cultured from six healthy individuals are shown in Table VIII .
At a 1:1 ratio of He yeast to M.0, both the percentage of Mo containing formazan
deposits and the total production of redox compound were significantly higher
(P < 0.01) than in unstimulated control Mo. The quantity of dye-reduced and
percentage of formazan-positive Mo at a 10:1 ratio of yeasts to phagocytes were
similar in amounts to those produced by incubation with PMA.
Hydrogen peroxide is one of the principal cytotoxic molecules elaborated by
Mo. To observe whether He stimulate the release of peroxide, M¢ were incu-
bated with He and the time course of peroxide release was measured by the
scopoletin assay (17) (Fig. 3). After a lag of 10-20 min, He initiated rapid release
of peroxide. The time course and amount of release induced by the addition of
10 He per MO corresponded closely with the response to IgG-coated glass beads,
a potent trigger of the oxidative burst. A lower dose of He (1 He per MO) caused
slower release. Yeast alone evolved no hydrogen peroxide, and the yeast had no
effect on the release caused by PMA.
Discussion
The early pathogenesis of disease caused by primary infection with He is
characterized by extensive multiplication of yeast forms within host MO. Thus,
the primary phase of Mo-yeast interaction is critical to successful parasitization
of MOs. In the present study, we have examined this interaction in vitro and
have demonstrated that attachment of yeasts to M-0 is achieved by a mechanism
that is not dependent on serum opsonins. Attachment of He yeasts does not
require FcR (Table V), mannose receptors (Tables 111, VII), a-glucan receptors,
or Mo-derived complement proteins (Table VI). The attachment of He does,
however, require warm temperatures and the presence of divalent cations. These
two properties are characteristics of the Mo receptors, CR3 (14, 31) and LFA-1
(32).
CR3 and LFA-1 are members ofa family of cell surface proteins that function
in cell adhesion . CR3 mediates attachment of C3bi-coated particles (7), LFA-1
Stimulus
Qualitative analysis Quantitative analysis
Percent NBT` MO (OD)
None 18.8 ± 1 .4 0.048 ± 0.010
He/M46 (1 :1) 57.8 ± 4.7 0.153 ± 0.01 .9
He/M0 (10 :1) 86.1 ± 1 .5 0.270 ± 0.024
PMA 83.9 ± 1 .4 0.256 ± 0.025O
a
X
a
2.4
2.2
2.0
1 .8
1 .6
1 .4
0
c
1 .0
0.8
a 0.6
0 0.4
N
2 0.2
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Hydrogen peroxide production by 7-d cultured MO in control cultures (x), and
in cultures incubated with I He yeast per Mo (/), or 10 yeasts per Mm (p). In positive controls,
Mo cultures Avere stimulated with IgG-coated beads (A) or PMA, 100 ng/ml (*). Both act as
potent triggers of H 101 to production . The effect of adding 10 He yeasts per Mo to cultures
stimulated with PMA was measured in an additional control (0).
mediates the attachment to tumor cells and endothelial cells (33, 34), and the
function of a third protein, p150,95, has not yet been determined. Mo express
approximately equal amounts of these three proteins on their cell surface
(Wright, S. D., unpublished observations). Each molecule of the CR3/LFA-
1/p 150,95 family contains a unique a subunit that is associated noncovalently
with a common a subunit (M,_, 95,000) in an a, al configuration. Both the a
chains and the common ,0 chain are surface-exposed .
To test whether members of the CR3/LFA-1/p150,95 family mediate the
recognition of Hc, we used soluble anti-receptor antibodies in blocking experi-
ments. Incubation of Mo with specific mAb directed against the a chains of each
member of the family of adherence-promoting proteins partially reduced the AI
of He yeasts. On the other hand the mAbs IB4 and 60.3 both directed against
the common (3 chain, greatly reduced the Al . Further studies used substrate-
bound mAbs to physically remove receptors from the apical surfaces of MO.
Removal of CR3, LFA-l, and p150,95 by a combination of three mAbs to each
of the specific a chains effected a substantial reduction in binding of yeasts (Fig.
2). A comparable blockade wasachieved with theanti-fl mAb IB4. mAbs directed
to other surface antigens, including the low-avidity FcR, failed to reduce the Al.
These findings indicate that binding of unopsonized He yeasts is mediated by
the CR3, LFA-1, p150,95 family.
We have also observed that removal of a single member of the CR3/LFA-
1/p150,95 family causes only a negligible decrease in the binding of Hc, and
removal of any pair of receptors lowers but does not eliminate binding (Fig. 2).
Thus, it appears that the capacity to recognize He is a property shared by all
three members of the CR3/LFA-1/p150,95 family.
The structural basis for the observation that all three members of the206
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CR3/LFA-1/p150,95 family share the ability to recognize He is not clear. One
possibility is that the recognition site for He is located on the shared ,0 chain.
This would explain the requirement that all three family members must be
removed from Mo to fully inhibit binding of He (Fig. 2), and the capacity of
soluble anti-,Q antibodies (IB4 and 60.3) to inhibit binding of He (Table II). The
binding site for C3bi, on the other hand, appears to be on the a chain of CR3
since LFA-1 and p150,95 do not recognize C3bi (31), and the anti-a mAb,
OKM 10, directly blocks the binding of C3bi to CR3 (7). Thus, CR3 may express
two distinct binding sites, one for C3bi on the a chain, and the other for He on
the # chain. Such a view is consistent with experiments of Ross et al ., who suggest
that CR3 expresses a lectin-like binding site that is distinct from the C3bi-binding
site (35). An alternative explanation for the data is that He express a variety of
surface structures, some of which are recognized via the a chain of CR3, others
by LFA-1, and others by p150,95. Currently, we cannot eliminate this possibility.
One of the mechanisms by which intracellular pathogens may enhance their
survival within phagocytes is by a failure to trigger the secretion of toxic oxygen
metabolites. We have observed, however, that He yeasts do induce generation
of superoxide anion by MO, as measured by NBT reduction (Table VIII), and
also promote the release of H202 under the conditions used in the present study.
In fact, the time course and extent of H202 release was comparable to that
induced by IgG-coated particles (Fig. 3). Since by electron microscopic exami-
nation, many ingested He appear to remain viable within human MO 120 min
after ingestion, (Detmers, P. A., and W. E. Bullock, unpublished observations),
we assume that He (strain 217B) is relatively resistant to destruction by toxic
oxygen metabolites.
The capacity of He to initiate the release of peroxide was surprising in view of
previous work (36) showing that ligation of CR3 by C3bi did not lead to its
release. Since He is recognized by LFA-I and p150,95 in addition to CR3, it is
possible that these receptors differ from CR3 or can synergize with CR3 in such
a fashion as to initiate release of peroxide. Alternatively, He may bear ligands
for other types of receptors and these may initiate peroxide release after CR3,
LFA-1, or p150,95 bind the yeast to the M(p surface. Still another explanation
for these results is the hypothesis of Ross et al. (35) that CR3 contains two
binding sites, one for C3bi that does not initiate an oxidative burst and a second
site that does. Experiments are underway to explore these possibilities.
The biochemical nature of the structure(s) on He that are recognized by MO
remains to be determined. Since the cell wall of He is composed principally of
carbohydrate (31), we sought evidence that receptors on MO act as lectins.
However, mannose, fucose, a-methyl mannoside, glucuronic acid, glucosamine,
N-acetyl glucosamine, galactose, galactosamine, ,B-glucan, and yeast mannan
failed to blockbinding (Table VII). Thefailureof Mo mannosyl/fucosyl receptors
to bind He may derive in part from the low mannose content of He cell walls (1-
5%) (30) as contrasted with avid binding to other yeasts with cell walls of high
mannose content, for example, Candida species(37) andS. cerevisiae (38). Recent
experiments (39) suggest that phosphosugars may be more likely candidates for
the recognition site. CR3, LFA-1, and p150,95 all bind to bacterial LPS. The
portion of LPS that is recognized is the diglucosamine bisphosphate headBULLOCK AND WRIGHT
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structure of lipid A (31). It is thus of interest that five novel phosphoinositol-
sphingolipids have been purified recently from the yeast phase of He (40, 41).
These sphingolipidspossess an identical inositol phosphoceramide core butdiffer
by the glycosyl substitution ofthepolarhead groups (40). Studies of theblocking
activity by these compounds will be of particular value in future work.
The present studies have established that unopsonized He yeasts are bound to
MO by the CR3/LFA-1/p150,95 adherence glycoproteins. In our view, it is
primarily by this mechanism that the organismsare provided a means forgaining
critical entry into a host cell that is highly permissive of yeast multiplication.
Thus, successful parasitization ofthe host isensured before maturation ofspecific
cell-mediated immune responses that render MO capable of restricting yeast cell
growth . By virtue of their location, alveolar MO are presumably among the first
phagocytes to come into contact with invasive yeast forms of He in the setting of
natural infection. However, certain properties of these cells differ from mono-
cyte-derived MO or M¢ obtained from other anatomic sites (42). Therefore,
further studies are required to establish the receptor mechanism(s) and the
kinetics ofbinding to He yeasts by human alveolar Mo.
Summary
The principal host cell of H. capsulatum (Hc) is the MO within which the
pathogenic yeast phase ofthe fungus multiplies during active disease. The initial
interaction between He yeasts and Mo therefore is a crucial step in the patho-
genesis of histoplasmosis. In the present study, we have identified the major
receptor mechanism that mediates the attachment of unopsonized He yeasts to
human monocyte-derived MO from peripheral blood. Binding of He yeasts by
MO is rapid, temperature dependent, and requires both Ca and Mg ions for
optimum activity. Recognition of He yeasts does not require Fc receptors,
mannosyl/fucosyl receptors, (3-glucan receptors, or secretion of C3 by Mo.
Studies were performed on the effect of down regulating specific receptors of
the CR3/LFA-1/p150,95 adherence-promoting protein family from the apical
portion ofMo to determine the effects upon binding ofHe yeasts. Anti-(3 chain
mAbs that recognize all three of these proteins blocked binding of yeasts.
However, removal ofindividual receptors with antibodies against the a polypep-
tides caused negligible depression of binding, and removal of any pair caused
only modest depression. Thus, each ofthe members of the CR3/LFA-I/p150,95
family is independently capable of binding Hc. The delineation of this new
mechanism for nonopsonic recognition by MO that is exploited by He yeasts will
aid in future studies to identify the He ligand, to elucidate the stoichiometry of
CR3/LFA-1/p150,95 binding, and to determine triggering mechanisms for
release of toxic oxygen metabolites.
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